Advances in Immuno-Oncology USA Congress

11 October - 12 October, 2018

marketing@oxfordglobal.co.uk

+44 (0)1865 248455

www.oxfordglobal.co.uk/immunooncologyusa-congress

San Diego Convention Center, USA

Organized By:

Oxford Global Marketing Ltd

+44 (0)1865 248455

info@oxfordglobal.co.uk

https://www.oxfordglobal.co.uk/

Part 1st Floor Godstow Court, Minns Business Park, Botley, Oxford

About Advances in Immuno-Oncology USA Congress

Join over 350 delegates from global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Over 20 presentations, case studies and panel discussions focusing on the latest innovations in Car-T cell development, patient stratification and assay developments in the immuno-oncology world.

2 Interactive Streams:

Development of Immuno-Oncology Therapies – Stream 1 features presentations on the latest developments in T Cell Engagers, cell based functional assays for IDO inhibitors, harnessing novel immune escape mechanisms for cancer therapeutics and toxicities with immuno-oncology therapy
Translational Immuno-Oncology and Clinical Development – Stream 2 addresses talks on the latest patient stratification innovations in immuno-oncology, identifying immunological biomarkers for precision cancer immunotherapy and Biomarker based selections in clinical trials.

Speakers

Speaker

More...

Visitors Profile

The Advances in Immuno-Oncology USA Congress is an exclusive event consisting of world-class keynote addresses and panel discussions designed specifically for senior level attendees from leading pharmaceutical, biotechnology, diagnostic, academic, government and solution provider companies. Delegates typically include VPs, Directors, Managers and Heads of: